KT

Karyopharm Therapeutics Inc.: visa sponsorship and H-1B record

Newton, MASponsors actively

No open jobs from Karyopharm Therapeutics Inc. on VisaJob.us right now. Browse all visa sponsorship jobs.

Sponsorship history

Sponsors actively
13H-1B labor applications (LCA)100% certified
7H-1B petitions approved by USCISapproval rate 100% · 1 new
0Green card filings (PERM)no filings found
$140kMedian H-1B salaryfrom LCA filings
Fiscal yearH-1B LCAsUSCIS approvalsUSCIS denialsPERM
FY2026430—
FY2025810—
FY2024130—

Roles they sponsor most

  • clinical data manager3 LCAs · median $133k
  • manager regulatory operations2 LCAs · median $189k
  • associate director ist operations1 LCA · median $125k
  • associate director regulatory operations1 LCA · median $189k
  • biostatistician1 LCA · median $187k
  • clinical trial manager1 LCA · median $160k
  • gcp documentation specialist1 LCA · median $97k
  • manager regulatory operations1 LCA · median $140k
  • scientist analytical chemistry1 LCA · median $153k
  • statistical programmer1 LCA · median $124k

FAQ

Does Karyopharm Therapeutics Inc. sponsor H-1B visas?

Yes. Karyopharm Therapeutics Inc. filed 13 H-1B labor condition applications in the years covered by our data, 13 of them certified by the Department of Labor.

Does Karyopharm Therapeutics Inc. sponsor green cards?

We found no PERM labor certification filings under this name.

Is Karyopharm Therapeutics Inc. cap-exempt?

Karyopharm Therapeutics Inc. appears to be a regular cap-subject employer, so new H-1B workers need to be selected in the annual lottery.

Sources: U.S. Department of Labor OFLC disclosure data (H-1B/H-1B1/E-3 LCA, PERM), OFLC prevailing wage data, USCIS H-1B Employer Data Hub, E-Verify participating employers. Data loaded: LCA FY2024–FY2026, PERM, USCIS Data Hub, OFLC wages; updated 2026-10-03. Employers are matched by name, so records of companies with similar names can occasionally be mixed up. This is general information, not legal advice — talk to an immigration attorney about your case.